BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 10650846)

  • 1. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.
    Münchow N; Kosch A; Schobess R; Junker R; Auberger K; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S109-12. PubMed ID: 10650847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
    Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
    Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia.
    Junker R; Koch HG; Auberger K; Münchow N; Ehrenforth S; Nowak-Göttl U
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2568-72. PubMed ID: 10521389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
    Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
    Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines.
    Knöfler R; Siegert E; Lauterbach I; Taut-Sack H; Siegert G; Gehrisch S; Müller D; Rupprecht E; Kabus M
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S147-50. PubMed ID: 10650856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.
    Nowak-Göttl U; Wermes C; Junker R; Koch HG; Schobess R; Fleischhack G; Schwabe D; Ehrenforth S
    Blood; 1999 Mar; 93(5):1595-9. PubMed ID: 10029588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic risk factors in childhood stroke and venous thrombosis.
    Heller C; Becker S; Scharrer I; Kreuz W
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S117-21. PubMed ID: 10650849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
    Nowak-Göttl U; Sträter R; Heinecke A; Junker R; Koch HG; Schuierer G; von Eckardstein A
    Blood; 1999 Dec; 94(11):3678-82. PubMed ID: 10572079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain].
    Francès F; Portolès O; Gabriel F; Corella D; Sorlí JV; Sabater A; Alfonso JL; Guillén M
    Rev Med Chil; 2006 Jan; 134(1):13-20. PubMed ID: 16532157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.
    Kosch A; Junker R; Kurnik K; Schobess R; Günther G; Koch H; Nowak-Göttl U
    Thromb Res; 2000 Sep; 99(6):531-7. PubMed ID: 10974337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey.
    Sträter R; Vielhaber H; Kassenböhmer R; von Kries R; Göbel U; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S122-5. PubMed ID: 10650850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.
    Mandalà M; Curigliano G; Bucciarelli P; Ferretti G; Mannucci PM; Colleoni M; Ventura A; Peruzzotti G; Severi G; Pelicci PG; Biffi R; Orsi F; Cinieri S; Goldhirsch A
    Ann Oncol; 2004 Apr; 15(4):590-3. PubMed ID: 15033664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.